← Open Payments lookup

REBECCA GROCHOWSKI: Open Payments

NPI 1861046567 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$508 in 21 payments from 11 companies in 2025. Trend: 2023 $1,219 · 2024 $938 · 2025 $508

Food & beverage: $508
CompanyPaymentsAmount
Janssen Biotech, Inc.3$98
GlaxoSmithKline, LLC.3$67
Genentech USA, Inc.3$66
Merck Sharp & Dohme LLC2$53
AstraZeneca Pharmaceuticals LP3$51
E.R. Squibb & Sons, L.L.C.2$49
Novartis Pharmaceuticals Corporation1$46
Gilead Sciences, Inc.1$24
Stemline Therapeutics Inc.1$21
PFIZER INC.1$18

Products named: TECVAYLI, KEYTRUDA, KISQALI, RYBREVANT, OPDIVO, Itovebi, OJJAARA, Trodelvy.

Industry payments across MD — which companies pay providers there.